Clinical Trial Update: First in Human Study of AZD9592 in Solid Tumors [Phase 1]

View source ↗

Summary

First-in-human Phase 1 study of AstraZeneca’s AZD9592 in solid tumors is recruiting to evaluate safety, tolerability, and preliminary dosing in patients with ad…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Head and Neck Cancer
• Non-small Cell Lung Cancer
• Solid Tumors

Drugs mentioned

• AZD9592

Snippet

Sponsor: AstraZeneca | Conditions: Advanced Solid Tumours, Carcinoma Non-small Cell Lung | Phase 1 | Status: RECRUITING